The human body is an extremely complex molecular machine, the details of which can be followed through certain substances; so-called biomarkers. Unfortunately, it is not yet possible to monitor biomarkers live in patients when these are present in minuscule concentrations. Researchers at Eindhoven University of Technology have now developed a new technique that can become the plain and simple solution for the live and super-sensitive monitoring of biomarkers.
They report on it in Nature Communications.
Substances that are essential for the body, such as proteins and hormones, are present in the blood in pico- or nanomolar concentrations. These are concentrations comparable to 1 sugar grain dissolved in an Olympic-sized swimming pool – extremely low, and difficult to measure. In the Molecular Biosensing for Medical Diagnostics group at Eindhoven University of Technology, under the guidance of Professor Menno Prins, a sensing technology has been developed that enables the super-sensitive measurement of biomarker concentrations over time.
The technique is based on the fact that tiny particles in liquid are continuously in Brownian motion because water molecules collide with them. The researchers bound the particles through a nanostrand to a glass plate, causing the particles to wiggle back and forth. The biomarker to be measured binds temporarily to specific adhesive molecules that are fixed to both the particles and the plate. When a biomarker molecule attaches itself to both a wiggling particle and to the plate, the particle suddenly becomes attached, which greatly reduces its mobility – until the biomarker is released again.
The mobility of the particles, which are coupled to the transparent glass, could be easily observed by the researchers with light. They have given their technology the name BPM: Biomarker monitoring based on sensing of Particle Mobility. Every time a wiggling particle suddenly moves less, and then more, one biomarker molecule has been observed. The number of these events per minute reveals the concentration of the biomarker in the liquid with a high degree of sensitivity.
The principle is explained in this animation video: https:/
The beauty of the BPM sensor technology is that it has digital precision, and that both increases and decreases in biomarker concentration over time can be monitored. The technique has now been demonstrated for the monitoring of protein and DNA. The technology is widely applicable, because suitable adhesion molecules are available for almost all biomarkers.
This flexibility, combined with the sensitivity and the expected miniaturization of the technology, means that Prins and his fellow researchers have high expectations of the future for their technology. “We anticipate that a completely new class of sensors for the monitoring of biomarkers will emerge from this,” says the professor, so he is creating a start-up that will develop practical sensors and applications. One of the possibilities is to connect a sensor to a catheter with which patients in the operating room or in the intensive care unit can be accurately monitored. In addition to medical applications, Prins also thinks there are possibilities for monitoring biomolecules in industrial processes and water purification.
The Latest on: Monitoring of biomarkers
via Google News
The Latest on: Monitoring of biomarkers
- Global High-Sensitivity Cardiac Biomarker Market Forecast Covering Growth Inclinations & Development Strategies until 2028 on March 8, 2019 at 6:13 am
Industries along with various research organizations are working to develop new variants of high-sensitivity cardiac biomarkers that can be more accurate for monitoring cardiac problems in various age ... […]
- Inivata Publishes Positive Results of Clinical Validation and Utility Study for InVision® Liquid Biopsy Test on March 7, 2019 at 4:00 am
Although they cannot cover every biomarker and can’t give a diagnosis ... become the standard upfront approach to diagnosis and monitoring of NSCLC, sparing patients painful and invasive tissue ... […]
- Hepcidin May Enable Early Ruling Out of Contrast-Induced AKI on March 6, 2019 at 4:39 am
Serum hepcidin may be an early predictive biomarker for ruling out contrast-induced acute kidney injury (CI-AKI) after percutaneous coronary interventions (PCI), according to investigators. They repor... […]
- Vocal Biomarker Market Forthcoming Development Analyzed until 2027 | Key Players are IBM Corporation, Cogito Corporation, US Cargo Control, etc. on March 5, 2019 at 5:06 am
Remote health monitoring potential of vocal biomarkers is also gaining high interest among researchers worldwide, For example, Beyond Verbal and Mayo Clinic have collaborated for discovering vocal pat... […]
- Biomarkers Market is Determined to Reach US$ 70.0 billion by 2024 on March 4, 2019 at 6:09 am
Biomarkers are used for detection, screening, diagnosis, treatment and monitoring of cancer. The report covers detailed competitive outlook including the market share and company profiles of the key p... […]
- Biocept's Liquid Biopsy Test for ESR1 Biomarker Detection to be Featured in Poster Presentation at the 2019 AACR Annual Meeting on March 4, 2019 at 5:05 am
"We believe the validation of this assay to detect actionable biomarkers associated with metastatic breast cancer can provide information to aid in therapy selection and in monitoring patient response ... […]
- Liquid biopsy comparable to tissue biopsy in detecting biomarkers in NSCLC on March 1, 2019 at 7:31 am
This is incredible work that shows the power of these new approaches in allowing us to measure circulating cell-free biomarkers for the detection, monitoring and, in this case, actual treatment choice... […]
- New Wearables Cut Health Care Costs With Better Monitoring on March 1, 2019 at 4:43 am
"By monitoring people remotely and passively ... such as heart rate, and other biomarkers simply by a user standing barefoot on the scale. The makers use machine learning to intuit overall health tren... […]
- Researchers reveal promising biomarker for vascular disease relapse on February 28, 2019 at 5:44 am
The researchers’ findings suggest that monitoring MPO-ANCA is useful for predicting relapse ... indications that MPO-ANCA reappearance could be particularly useful as a biomarker for relapse of AAV wi... […]
via Bing News